[Molecular biomarkers for multiple system atrophy. (A systematic review)].
Multiple system atrophy (MSA) is a rare, rapidly progressive neurodegenerative disorder. Early diagnosis remains challenging because of clinical heterogeneity and symptom overlap with Parkinson's disease and other atypical parkinsonian syndromes. This systematic review synthesizes current evidence on molecular biomarke...